Timothy M. Miller

Department of Neurology, Washington University in St. Louis School of Medicine

Affiliated withWashington University in St. Louis School of Medicine

Research Area

Biography

Timothy M. Miller has not added Biography.
If you are Timothy M. Miller and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 170	2013

Other Publications

Article	Year
Has gene therapy for ALS arrived? Nature medicine\| PubMed ID: 14520369	2003
Proposed modification to data analysis for statistical motor unit number estimate. Muscle & nerve\| PubMed ID: 15116374	2004
Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annual review of neuroscience\| PubMed ID: 15217349	2004
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron\| PubMed ID: 15233913	2004
Medicine. Treating neurodegenerative diseases with antibiotics. Science (New York, N.Y.)\| PubMed ID: 15661995	2005
Virus-delivered small RNA silencing sustains strength in amyotrophic lateral sclerosis. Annals of neurology\| PubMed ID: 15852369	2005
Muscle cramps. Muscle & nerve\| PubMed ID: 15902691	2005
Should the Babinski sign be part of the routine neurologic examination? Neurology\| PubMed ID: 16247040	2005
Progressive spinal axonal degeneration and slowness in ALS2-deficient mice. Annals of neurology\| PubMed ID: 16802286	2006
Antisense oligonucleotide therapy for neurodegenerative disease. The Journal of clinical investigation\| PubMed ID: 16878173	2006
Amyotrophic lateral sclerosis and gene therapy. Nature clinical practice. Neurology\| PubMed ID: 16932606	2006
The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology. Birth defects research. Part A, Clinical and molecular teratology\| PubMed ID: 17036307	2006
Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17164329	2006
RCADiA: simple automation platform for comparative multidimensional protein identification technology. Analytical chemistry\| PubMed ID: 17616168	2007
Differential diagnosis of myotonic disorders. Muscle & nerve\| PubMed ID: 18067134	2008
Gene-targeted therapies for the central nervous system. Archives of neurology\| PubMed ID: 18268183	2008
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 18296640	2008
Mutation analysis in a population-based cohort of boys with Duchenne or Becker muscular dystrophy. Journal of child neurology\| PubMed ID: 19074751	2009
Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet). The Journal of pediatrics\| PubMed ID: 19394035	2009
TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19833869	2009
Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation. Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases\| PubMed ID: 20184521	2010
Use of corticosteroids in a population-based cohort of boys with duchenne and becker muscular dystrophy. Journal of child neurology\| PubMed ID: 20207610	2010
ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 21078990	2010
SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy. JAMA neurology\| PubMed ID: 23147550	2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet neurology\| PubMed ID: 23541756	2013